<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04560426</url>
  </required_header>
  <id_info>
    <org_study_id>PTIOP1.0</org_study_id>
    <nct_id>NCT04560426</nct_id>
  </id_info>
  <brief_title>Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation</brief_title>
  <official_title>Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This intraoperative parathyroid gland auxiliary recognition system uses the principle of&#xD;
      parathyroid gland autofluorescence to assist surgeons in accurately identifying and&#xD;
      protecting parathyroid glands during surgery, reducing the possibility of postoperative&#xD;
      hypoparathyroidism. This study will explore the protective effect of the parathyroid gland&#xD;
      auxiliary recognition instrument on parathyroid function during thyroid malignant tumor&#xD;
      surgery through reasonable grouping.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 31, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Calcium level</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Patients' serum Calcium level at 24 hours after surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Calcium level</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>Patients' serum Calcium level at 1 month after surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Patients' serum PTH level at 24 hours after surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>Patients' serum PTH level at 1 month after surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Parathyroid</condition>
  <condition>Intraoperative Monitoring</condition>
  <condition>Thyroid Cancer</condition>
  <arm_group>
    <arm_group_label>Naked eyes &amp; Instrument assistance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Identify the parathyroid glands through the experience of surgeons and assistance of instrument.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Naked eyes only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Identify the parathyroid glands only through the experience of surgeons.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraoperative parathyroid gland auxiliary recognition system</intervention_name>
    <description>The enrolled patients are grouped according to whether or not to use the intraoperative parathyroid auxiliary recognition system.</description>
    <arm_group_label>Naked eyes &amp; Instrument assistance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with unilateral thyroid malignancies who require surgical treatment between&#xD;
             the ages of 20-50.&#xD;
&#xD;
          2. No history of neck surgery and radiotherapy.&#xD;
&#xD;
          3. There is no evidence of parathyroid tumor invasion in preoperative imaging assessment.&#xD;
&#xD;
          4. No abnormal calcium metabolism disease.&#xD;
&#xD;
          5. No abnormalities in blood calcium and blood PTH before operation.&#xD;
&#xD;
          6. No allergy to contrast agents.&#xD;
&#xD;
          7. The patient or his agent signs an informed consent statement.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Does not meet the entry criteria;&#xD;
&#xD;
          2. Parathyroid glands were found to be invaded by tumor during operation and the&#xD;
             parathyroid glands could not be preserved.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yu Wang, Doctor</last_name>
    <phone>+86 13817311886</phone>
    <email>neck130@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fudan University Shanghai Cancer Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 29, 2020</study_first_submitted>
  <study_first_submitted_qc>September 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2020</study_first_posted>
  <last_update_submitted>September 21, 2020</last_update_submitted>
  <last_update_submitted_qc>September 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parathyroid Hormone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

